Logo
Cedar Grove Capital Management
Search
Subscribe
Sign In
Home
Archive
Authors
Table of Contents
In the Press
Podcast
Our Fund
Contact Us
Logo
Cedar Grove Capital Management
Oliver Buchannon
Paul Cerro

Former investment banker @MerrillLynch. Currently CIO of Cedar Grove Capital Management, a multi-strategy hedge fund.


IPO Notes: Suja Life (SUJA) is a Bet on...Soda?

Jun 1, 2026

•

11 min read

IPO Notes: Suja Life (SUJA) is a Bet on...Soda?

Why the decline in the recent IPO improves the R/R, but still leaves potential issues for investors looking to get involved

COTW: Restaurants Losing Their Glitz And Glam

May 21, 2026

•

2 min read

COTW: Restaurants Losing Their Glitz And Glam

Visualizing the decline in valuations in various restaurant concepts while highlighting which the market still seems to give hope to

The 'FOMO' Is Unbearably Real

May 15, 2026

•

6 min read

The 'FOMO' Is Unbearably Real

Why a recent post from a fellow portfolio manager got us thinking about the current FOMO environment, and why staying the course "generally" works out in the long term

The Sift No.1

May 5, 2026

•

7 min read

The Sift No.1

Analytical Perspectives on Equity Selection and Market Data.

NKTR: "Winning By Being Second"

Apr 19, 2026

•

12 min read

NKTR: "Winning By Being Second"

Why Nektar Therapeutics atopic dermatitis (AtD) drug could be significantly undervalued despite being a potential second-line drug treatment option

CGCM Q1'26 Quarterly Letter

Apr 10, 2026

•

4 min read

CGCM Q1'26 Quarterly Letter

Part 2: Q4 Earnings Update On High Conviction Investment - EVLV

Apr 2, 2026

•

13 min read

Part 2: Q4 Earnings Update On High Conviction Investment - EVLV

Quick update on EVLV and why we think that FY'26 guide hints at a long-term opportunity for price appreciation above $10/share.

Part 1: Q4 Earnings Updates and Capturing Cheap Growth? [REAL, KITS, WW]

Mar 23, 2026

•

25 min read

Part 1: Q4 Earnings Updates and Capturing Cheap Growth? [REAL, KITS, WW]

Going over Q4'25 earnings for current investors and why they might standout for new investors looking new areas for capital deployment

LNSR Terminates Deal - Is It Worth More Than the $14/Share?

Mar 17, 2026

•

13 min read

LNSR Terminates Deal - Is It Worth More Than the $14/Share?

A quick walkthrough on the math post-deal break, and could LNSR still be compelling as a standalone company?

Understanding "Risk" From One of the Greats — Howard Marks

Mar 15, 2026

•

15 min read

Understanding "Risk" From One of the Greats — Howard Marks

What one of the best investors on Wall Street has to say about "risk" and what we can learn from it

NVO's Pressure Forces HIMS to Pivot

Mar 10, 2026

•

14 min read

NVO's Pressure Forces HIMS to Pivot

What both bulls and bears need to understand is the financial impact of HIMS pivoting hard from the compounded GLP-1 strategy

IPO Notes: Unprofitable Once Upon A Farm (OFRM) Goes Public

Mar 6, 2026

•

27 min read

IPO Notes: Unprofitable Once Upon A Farm (OFRM) Goes Public

Taking a look at the recent OFRM IPO, co-founded by actress Jennifer Garner, and why it could be an interesting setup for the newest CPG brand to hit the market

Quick Special Situation: Restaurant Take-Private w/ Potential Bidding War

Feb 16, 2026

•

8 min read

Quick Special Situation: Restaurant Take-Private w/ Potential Bidding War

Why this prized restaurant asset could strike up a bidding war amongst bidders looking to shore up their position in the quick service restaurant (QSR) space. Potential return could be in excess of 35%.

HIMS: Napoleon Watches Moscow Burn

Feb 9, 2026

•

24 min read

HIMS: Napoleon Watches Moscow Burn

Why we think Andrew's push deep into compounding GLP-1 land (Russia) has now reached its peak, and the drop is looking like quite the tumble.

🎙️ IC #9: Talking Telehealth and HIMS w/ Ashwin Sharma

Feb 4, 2026

•

6 min read

🎙️ IC #9: Talking Telehealth and HIMS w/ Ashwin Sharma

Our chat on all things telehealth and our views on HIMSwith our medical friend from across the pond

Special Situation: All Eyes on ABVX

Feb 4, 2026

•

19 min read

Special Situation: All Eyes on ABVX

Why we think this biotech trade, while popular, has limited downside risk in the event no suitor comes to scoop them up.

Quick Update - LE Gets A JV: +115% IRR // Trade Still In Play

Jan 27, 2026

•

8 min read

Quick Update - LE Gets A JV: +115% IRR // Trade Still In Play

Going over the announced LE joint venture by WHP and how there is still a trade on the table

Big Changes Coming To SNAP

Jan 20, 2026

•

5 min read

Big Changes Coming To SNAP

Why recent amendments to SNAP in 2026 could spell trouble for legacy CPG companies

[COTW] How A $1.5 Trillion Military Compares

Jan 11, 2026

•

5 min read

[COTW] How A $1.5 Trillion Military Compares

Why comparing a side-by-side of just how much the U.S. spends on defense is alarming

Fear-Based Investing - Part 2 // Future of Weapons Screening

Jan 5, 2026

•

34 min read

Fear-Based Investing - Part 2 // Future of Weapons Screening

Why a more dangerous everyday environment is allowing this stock to take advantage

🎙️ IC #8: Lessons From The Past

Dec 30, 2025

•

5 min read

🎙️ IC #8: Lessons From The Past

Sharing learning lessons from 2025 investments to not repeat them // HIMS, GENK, LQDA, REAL

Our 6 Investment Themes for 2026

Dec 22, 2025

•

4 min read

Our 6 Investment Themes for 2026

What we're looking at ahead of the next year, and why they matter

Fear-Based Investing - Part 1 // +226%

Dec 9, 2025

•

21 min read

Fear-Based Investing - Part 1 // +226%

An update on Owlet (OWLT) after a ~226% run-up

🎙️ IC #7: A Phoenix Rising From the Ashes - Talking Weight Watchers (WW) Post-Bankruptcy

Dec 2, 2025

•

5 min read

🎙️ IC #7: A Phoenix Rising From the Ashes - Talking Weight Watchers (WW) Post-Bankruptcy

An open discussion with David Helderman, Director of Investor Relations at WW International (WW)

IPO Notes: Gloo Holdings (GLOO) Nosebleed Valuation is Higher Than Heaven

Nov 19, 2025

•

27 min read

IPO Notes: Gloo Holdings (GLOO) Nosebleed Valuation is Higher Than Heaven

Why we think this new IPO is doomed to fail

Load more

Cedar Grove Capital Management

Multi-strategy equity research focused on L/S, M&A Arb, and other Special Situations.

© 2026 Cedar Grove Capital Management.
beehiivPowered by beehiiv